Provayblue
Drug
Provepharm Inc.
Total Payments
$335,195
Transactions
34
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $210,792 | 12 | 0 |
| 2019 | $84,728 | 16 | 3 |
| 2018 | $33,313 | 4 | 1 |
| 2017 | $6,364 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $334,177 | 29 | 99.7% |
| Travel and Lodging | $751.13 | 2 | 0.2% |
| Food and Beverage | $267.48 | 3 | 0.1% |
Payments by Type
Research
$334,177
29 transactions
General
$1,019
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prospective Registry | Provepharm Inc. | $148,273 | 1 |
| MB improves outcomes w/patients with Covid 19 | Provepharm Inc. | $66,150 | 0 |
| PVP201603 | Provepharm Inc. | $62,694 | 0 |
| MB as a 3rd line Vasopressor in Septic Shock | Provepharm Inc. | $52,047 | 0 |
| Sentinel Lymph Node | Provepharm Inc. | $2,700 | 1 |
| MEBIPAM - MEthylene Blue In Patients with Acquired Methemoglobinemia | Provepharm Inc. | $2,314 | 1 |
Top Doctors Receiving Payments for Provayblue
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Radnor, PA | $326,538 | 26 |
| , MD | Internal Medicine | Jamestown, RI | $3,158 | 3 |
| , MD | Surgery | Tampa, FL | $2,700 | 1 |
| , M.D | Pediatrics | Louisville, KY | $2,314 | 1 |
| , MD, MTM&H | Internal Medicine | Bethesda, MD | $471.48 | 2 |
| , MD | Emergency Medicine | Radnor, PA | $14.14 | 1 |
Ad
Manufacturing Companies
- Provepharm Inc. $335,195
Product Information
- Type Drug
- Total Payments $335,195
- Total Doctors 5
- Transactions 34
About Provayblue
Provayblue is a drug associated with $335,195 in payments to 5 healthcare providers, recorded across 34 transactions in the CMS Open Payments database. The primary manufacturer is Provepharm Inc..
Payment data is available from 2017 to 2020. In 2020, $210,792 was paid across 12 transactions to 0 doctors.
The most common payment nature for Provayblue is "Unspecified" ($334,177, 99.7% of total).
Provayblue is associated with 6 research studies, including "Prospective Registry" ($148,273).